US FDA approves updated indication statement for AbbVie’s Rinvoq for the treatment of inflammatory bowel disease: North Chicago, Illinois Wednesday, October 15, 2025, 12:00 Hrs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback